Susquehanna International Group, LLP Adaptive Biotechnologies Corp Transaction History

Susquehanna International Group, LLP

$641 Billion
Q4 2024

A detailed history of Susquehanna International Group, LLP transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Susquehanna International Group, LLP holds 51,565 shares of ADPT stock, worth $426,442. This represents 0.0% of its overall portfolio holdings.

Number of Shares

51,565

Previous 110,139 53.18%

Holding current value

$426,442

Previous $563,000 45.12%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$4.37 - $6.78 $255,968 - $397,131	-58,574 Reduced 53.18%	51,565 $309,000
Q3 2024 Nov 14, 2024	SELL	$3.37 - $5.12 $958,033 - $1.46 Million	-284,283 Reduced 72.08%	110,139 $563,000
Q2 2024 Aug 15, 2024	BUY	$2.34 - $3.96 $666,359 - $1.13 Million	284,769 Added 259.7%	394,422 $1.43 Million
Q1 2024 May 07, 2024	SELL	$2.88 - $4.8 $35,156 - $58,593	-12,207 Reduced 10.02%	109,653 $351,000
Q4 2023 Feb 14, 2024	BUY	$3.46 - $5.33 $143,756 - $221,450	41,548 Added 51.73%	121,860 $597,000
Q3 2023 Nov 14, 2023	SELL	$5.07 - $8.44 $454,890 - $757,253	-89,722 Reduced 52.77%	80,312 $437,000
Q2 2023 Aug 11, 2023	BUY	$6.19 - $8.78 $347,358 - $492,698	56,116 Added 49.26%	170,034 $1.14 Million
Q1 2023 May 16, 2023	BUY	$7.8 - $10.11 $669,739 - $868,085	85,864 Added 306.07%	113,918 $1.01 Million
Q4 2022 Feb 14, 2023	SELL	$6.26 - $9.34 $29,766 - $44,411	-4,755 Reduced 14.49%	28,054 $214,000
Q3 2022 Nov 14, 2022	SELL	$6.5 - $12.67 $456,144 - $889,129	-70,176 Reduced 68.14%	32,809 $234,000
Q2 2022 Aug 15, 2022	BUY	$6.4 - $14.73 $215,660 - $496,356	33,697 Added 48.63%	102,985 $833,000
Q1 2022 May 16, 2022	BUY	$10.12 - $28.9 $270,082 - $771,283	26,688 Added 62.65%	69,288 $962,000
Q4 2021 Feb 14, 2022	BUY	$25.17 - $36.85 $75,988 - $111,250	3,019 Added 7.63%	42,600 $1.2 Million
Q3 2021 Nov 15, 2021	SELL	$30.02 - $39.87 $1.56 Million - $2.07 Million	-52,003 Reduced 56.78%	39,581 $1.35 Million
Q2 2021 Aug 11, 2021	BUY	$32.22 - $44.59 $921,330 - $1.28 Million	28,595 Added 45.4%	91,584 $3.74 Million
Q1 2021 May 17, 2021	BUY	$37.26 - $67.74 $2.02 Million - $3.68 Million	54,337 Added 628.03%	62,989 $2.54 Million
Q4 2020 Feb 16, 2021	SELL	$45.01 - $65.47 $3.36 Million - $4.89 Million	-74,721 Reduced 89.62%	8,652 $512,000
Q2 2020 Aug 14, 2020	SELL	$24.95 - $48.38 $1.05 Million - $2.04 Million	-42,253 Reduced 33.63%	83,373 $4.03 Million
Q1 2020 May 15, 2020	BUY	$16.96 - $34.16 $1.08 Million - $2.17 Million	63,505 Added 102.23%	125,626 $3.49 Million
Q4 2019 Feb 14, 2020	BUY	$24.56 - $32.8 $511,363 - $682,928	20,821 Added 50.41%	62,121 $1.86 Million
Q3 2019 Nov 14, 2019	BUY	$30.31 - $53.51 $1.25 Million - $2.21 Million	41,300 New	41,300 $1.28 Million

Others Institutions Holding ADPT

# of Institutions

225

Shares Held

146M

Call Options Held

19.6K

Put Options Held

27.2K

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $1.18B
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Adaptive Biotechnologies Corp Transaction History